Cis-platinum-diammino-dichloro (CPDD) in chemotherapy of cancers: Phase II therapeutic trial
- 9 December 1978
- Vol. 60 (9) , 935-940
- https://doi.org/10.1016/s0300-9084(78)80578-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cis‐diamminedichloroplatinum (NSC‐119875) in childhood malignancies: A southwest oncology group studyMedical and Pediatric Oncology, 1978
- High dose Cis-platinum diammine dichloride.Amelioration of renal toxicity by mannitol diuresisCancer, 1977
- Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)Cancer, 1972
- cis-dichlorodiammineplatinum(II): Hematopoietic effects in ratsToxicology and Applied Pharmacology, 1971
- CIS-dichlorodiammineplatinum (II)Biochemical Pharmacology, 1970
- Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitroInternational Journal of Cancer, 1970
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965